Zepbound
product on 9 shows · 4 statements across 2 episodes · said 22 times in 10 episodes since 2024
Cheeky Pint 9 
Acquired 2 
Innovators & Investors 2 
BigDeal 2 
All-In 2 
TBPN 2 
Invest Like the Best 1 
Sourcery 1 
the a16z Podcast 1
Mentions by year, every show
tap a year for its mentions
Cheeky Pint 9Acquired 2All-In 2BigDeal 2TBPN 2Innovators & Investors 2the a16z Podcast 1Sourcery 11 more shows
2026 3 mentions in 2 episodes 2 per episode
2025 16 mentions in 6 episodes 3 per episode
- Dave Ricks, CEO of Eli Lilly, on GLP-1s and the business of pharma
- Ozempic Expert: They’re Lying To You About Getting Fat | Dr. Tyna Moore
- REVIEW: HIMS Super Bowl Ad (Controversy)
- Tucker Carlson and Mark Cuban Debate How to Save America 🔥 | All-In Summit 2025
- Meme Lord CEO Raises $22.5M Series A for Hello Patient · Sourcery with Molly O'Shea
- 7 More Healthy Years: What We Can Learn from Super Agers
- every mention in 2025, scene by scene →
2024 3 mentions in 2 episodes 2 per episode
every mention on every show, scene by scene, with the transcript →
4 statements about Zepbound, every show
Ricks: ICER found tirzepatide and semaglutide cost-effective at current pricing
“They just analyzed our medicines, trisepatide and semaglutide, and they said, actually, they're both cost effective at current pricing. In fact, Zepbound or Trisepatide was, the threshold they have is to save a 100,000 dollars per person per year in downstream…”
Ricks: Taltz plus Zepbound trial is certain to boost psoriasis efficacy
“So we're doing a study with our psoriasis drug, Taltz, and ZepBound. That will read out this fall. And I'm certain we'll show a boost in efficacy with the weight loss.”
Ricks: Self-pay Zepbound is the #1 prescribed form of GLP-1s
“Actually, the number one prescribed form of these medications is Zep-bound self-buy. We sell more than that than our insured business, a new patient starts, and more than all of we go.”